STOCK TITAN

Albemarle (NYSE: ALB) CEO sells 11,783 shares, gifts 30,716

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Albemarle Corporation Chairman & CEO J. Kent Masters reported both stock sales and a gift of shares. On March 10, 2026, he sold a total of 11,783 shares of Albemarle common stock in open-market transactions at weighted-average prices with ranges from $169.63 to $171.89 per share for diversification and tax planning purposes. After these sales, he directly held 134,628 shares.

On March 12, 2026, he made a bona fide gift of 30,716 shares, transferring them to an irrevocable trust over which he has no influence or control. Following this transfer, he directly holds 103,912 shares, which the disclosure notes remain in excess of his required holdings under Albemarle’s stock ownership guidelines.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Masters J Kent

(Last) (First) (Middle)
ALBEMARLE CORPORATION
4250 CONGRESS STREET, SUITE 900

(Street)
CHARLOTTE NC 28209

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman & CEO
3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/10/2026 S 5,395 D $170.26(1) 141,016 D
Common Stock 03/10/2026 S 5,392 D $171.18(2) 135,624 D
Common Stock 03/10/2026 S 996 D $171.82(3) 134,628 D
Common Stock 03/12/2026 G 30,716 D $162.79(4) 103,912 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $169.63 to $170.62, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines.
2. The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $170.63 to $171.57, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines.
3. The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person for diversification and tax planning purposes in multiple transactions, at prices ranging from $171.67 to $171.89, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines.
4. For tax and estate planning purposes, these shares were transferred to an irrevocable trust over which the reporting person has no influence or control. The reporting person retains significant holdings in Albemarle stock, in excess of his required holdings under Albemarle stock ownership guidelines.
Remarks:
EX-24 - Power of Attorney
/s/ Corey E. Tanner, Attorney-in-fact 03/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Albemarle (ALB) CEO J. Kent Masters report?

J. Kent Masters reported both sales and a gift of Albemarle stock. He sold 11,783 common shares in open-market transactions on March 10, 2026, and gifted 30,716 shares to an irrevocable trust on March 12, 2026, while retaining a substantial direct holding.

How many Albemarle (ALB) shares did the CEO sell and at what prices?

The CEO sold 11,783 Albemarle common shares. These open-market sales on March 10, 2026, occurred at weighted-average prices with ranges from $169.63 to $171.89 per share, and were described as for diversification and tax planning purposes.

How many Albemarle (ALB) shares did the CEO gift to a trust?

He gifted 30,716 Albemarle shares. On March 12, 2026, these shares were transferred as a bona fide gift to an irrevocable trust for tax and estate planning purposes, and he is stated to have no influence or control over that trust.

How many Albemarle (ALB) shares does the CEO still hold after these transactions?

After the reported transactions, he directly holds 103,912 shares. The disclosure notes that this remaining position represents significant holdings and exceeds his required ownership level under Albemarle’s stock ownership guidelines.

What reasons were given for the Albemarle (ALB) CEO’s stock sales?

The stock sales were described as diversification and tax planning moves. Footnotes explain that the March 10, 2026 open-market transactions were executed for diversification and tax planning purposes, with detailed price ranges available upon request from the company or regulators.

Does the Albemarle (ALB) CEO control the shares transferred to the irrevocable trust?

No, he is stated to have no influence or control over that trust. The filing specifies that the 30,716 gifted shares went to an irrevocable trust for tax and estate planning purposes, and clarifies his lack of control over those trust-held shares.
Albemarle Corp

NYSE:ALB

View ALB Stock Overview

ALB Rankings

ALB Latest News

ALB Latest SEC Filings

ALB Stock Data

19.54B
117.35M
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
CHARLOTTE